Overtreatment and associated risk factors among multimorbid older patients with diabetes.

Oliver Baretella,Heba Alwan,Martin Feller,Carole E Aubert,Cinzia Del Giovane,Dimitrios Papazoglou,Antoine Christiaens,Arend-Jan Meinders,Stephen Byrne,Patricia M Kearney,Denis O'Mahony,Wilma Knol,Benoît Boland,Baris Gencer,Drahomir Aujesky,Nicolas Rodondi

Journal of the American Geriatrics Society（2023）

引用 0|浏览6

暂无评分

摘要

In this multicountry study of multimorbid older patients with T2DM, more than one third were overtreated, highlighting the high prevalence of this problem. Careful balancing of benefits and risks in the choice of GLM may improve patient care, especially in the context of comorbidities such as severe renal impairment, and frequent non-GP healthcare contacts.

查看译文

关键词

glucose-lowering medication, HbA(1c), multimorbidity, polypharmacy, type 2 diabetes mellitus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要